Daejoo대주산업
003310 · KOSDAQ · ₩003310 · 대주산업
₩1,474▼ ₩21 (1.40%)End-of-day · Oct 30, 2026 · End-of-day prices.
Income statement
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₩25B | ₩25B | ₩27B | ₩24B | ₩25B | ₩26B | ₩29B | ₩25B |
| Cost of sales | ₩19B | ₩19B | ₩20B | ₩18B | ₩19B | ₩19B | ₩21B | ₩19B |
| Gross profit | ₩6.3B | ₩6.3B | ₩6.7B | ₩6.4B | ₩5.9B | ₩6.6B | ₩7.5B | ₩5.5B |
| Operating income | ₩2.6B | ₩2B | ₩3.5B | ₩2.5B | ₩2.1B | ₩2.6B | ₩3.5B | ₩2.3B |
| Net income | ₩366M | ₩1.6B | ₩4.9B | ₩9.8M | −₩180M | ₩2B | ₩6.3B | ₩800M |
| Net income to shareholders | ₩1.9B | ₩1.6B | ₩977M | ₩1.9B | ₩1.9B | ₩2B | ₩2.5B | ₩2B |
Balance sheet
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Total assets | ₩147B | ₩147B | ₩147B | ₩114B | ₩114B | ₩114B | ₩111B | ₩114B |
| Current assets | ₩41B | ₩40B | ₩39B | ₩37B | ₩37B | ₩37B | ₩34B | ₩38B |
| Cash and equivalents | ₩8.6B | ₩15B | ₩15B | ₩15B | ₩16B | ₩16B | ₩11B | ₩5.1B |
| Total liabilities | ₩33B | ₩35B | ₩35B | ₩26B | ₩28B | ₩30B | ₩28B | ₩33B |
| Current liabilities | ₩15B | ₩16B | ₩17B | ₩14B | ₩15B | ₩17B | ₩15B | ₩20B |
| Borrowings | ₩5B | ₩4.5B | ₩3.8B | ₩4.3B | ₩7.1B | ₩7.5B | ₩6.1B | ₩8.6B |
| Total equity | ₩114B | ₩112B | ₩112B | ₩88B | ₩86B | ₩84B | ₩84B | ₩81B |
| Shareholders' equity | ₩114B | ₩112B | ₩112B | ₩88B | ₩86B | ₩84B | ₩84B | ₩81B |
Cash flow
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | ₩2.1B | ₩2.9B | ₩4.4B | ₩3.1B | ₩3.2B | ₩4.2B | ₩3.3B | ₩2.6B |
| Capital spending | ₩278M | ₩173M | ₩114M | ₩793M | ₩599M | ₩708M | ₩1.5B | ₩623M |
| Free cash flow | ₩1.8B | ₩2.7B | ₩4.3B | ₩2.3B | ₩2.6B | ₩3.5B | ₩1.8B | ₩2B |
| Dividends paid | ₩51,270 | ₩1.3B | ₩0 | ₩0 | ₩2.8B | −₩1.4B | ₩197,070 | ₩0 |
Consolidated where available. Amounts in won.
Also known as: Daejoo / 대주산업 / 003310 / KRX:003310
Source: KRX statistical information